Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Press Releases

Read current and past press releases outlining the latest news and announcements from The Lustgarten Foundaiton.

2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016  | 2017

2017 Press Releases

Lustgarten Foundation Launches Online Support Community

WOODBURY, NY (November 6, 2017) – Today the Lustgarten Foundation for Pancreatic Cancer Research in partnership with Let’s Win, an initiative supported by the Foundation, and Inspire launched an online support community, Pancreatic Cancer Connections, which provides a safe space for pancreatic cancer patients and their loved ones to share their experiences, get valuable coping resources, and support one another. Inspire is a leading healthcare social network that connects more than 1,000,000 patients and caregivers. Read More...


Lustgarten Foundation and Stand Up To Cancer Announce Two New Pancreatic Cancer Research Projects Focused on Doubling the Number of Surgical Interventions

Woodbury, NY (October 26, 2017) – The Lustgarten Foundation and Stand Up To Cancer (SU2C) announced today the launch of two new pancreatic cancer interception research projects – one focused on earlier detection and the other on surgical intervention. The total investment for these projects is nearly $10 million and will involve thousands of patients.“We are pleased to once again join forces with Stand Up To Cancer,” said Dr. Robert Vizza, the Foundation’s Vice Chairman, Research. “Since only 15% of pancreatic cancer patients are currently eligible for surgery, if we are able to diagnose patients earlier and increase the number of patients who can have surgery, we will significantly increase survival rates.”  Read More...


Let’s Win! Inducted into the PR News Platinum Hall of Fame

New York, NY, September 14, 2017 – Today Finn Partners announced that Let’s Win, an initiative supported by the Lustgarten Foundation, is being inducted into the PR News Platinum Hall of Fame today at the national trade publication’s PR & Agency Elite Awards luncheon. Let’s Win and its late founder, Anne Glauber, are being honored for inspiring communications to better serve pancreatic cancer patients, their families and all those touched by the disease. When diagnosed with pancreatic cancer, Anne was a Finn Partners managing partner and founder of its CSR/Social Impact Practice. The Agency’s CSR/Social Impact and Health Practice are the Let’s Win agency of record.  Read More...


NEW STUDY SHOWS PROMISING RESULTS IN THE DEVELOPMENT OF MORE EFFECTIVE BLOOD TEST TO DETECT PANCREATIC CANCER

WOODBURY, NY, September 5, 2017 A study published the week of September 4th in Proceedings of the National Academy of Science shows how combining mutations in circulating tumor DNA (ctDNA) with protein markers can result in a screening test with improved sensitivity (64% of early stage patients detected) while retaining very high specificity or accuracy (99.5% or less than 1% false positive). The combination of ctDNA and protein markers was superior to any single marker alone. This work was funded in part by the Lustgarten Foundation which is the largest private funder of pancreatic cancer research. Read More...


Mechanism of metastasis is discovered in pancreatic cancer

WOODBURY, NY, July 27, 2017 – Lustgarten Foundation funded research discovered a mechanism of metastasis in pancreatic cancer, and perhaps, other cancer types as well. The Foundation’s dedicated lab at Cold Spring Harbor Laboratory (CSHL) used organoid technology to find that pancreatic cancer cells reprogram gene enhancers to achieve the ability to spread. The research, appearing online today in Cell, provides strong evidence supporting this explanation of metastasis, which is the cause of most cancer deaths. Experiments conducted by postdoctoral investigators of the Vakoc and Tuveson labs at CSHL, focused on cells of the pancreas since most pancreatic cancer cases culminate in metastasis.  Read More...


LUSTGARTEN FOUNDATION TO COMMIT $40 MILLION TO PANCREATIC CANCER RESEARCH IN 2017-18

Woodbury, N.Y., July 12, 2017 The Lustgarten Foundation announced today that it will commit an unprecedented $40 million in 2017-18 through its new Translational Clinical Program, expanded Research Investigator Award Program and other partnerships. This is the first time any pancreatic cancer organization will commit that level of funding in a condensed period of time. As part of the Foundation’s research strategy, it will fund significant research projects in the areas of earlier detection, personalized medicine and developing new therapeutics with improved drug delivery. Read More...


LUSTGARTEN FOUNDATION FUNDED RESEARCH FINDS T CELL PROXIMITY TO PANCREATIC CANCER CELLS CORRELATES WITH INCREASED PATIENT SURVIVAL

BETHPAGE, N.Y., May 1, 2017 Findings reinforce the importance of immunotherapy research. Lustgarten Foundation’s funded research found that spatial distribution of cytotoxic T-cells in proximity to pancreatic ductal adenocarcinoma (PDAC) cancer cells correlates with increased patient survival. Desmoplasia, the growth of fibrous or connective tissue, causes dense fibrosis around the tumor making it difficult to treat the cancer. It has been hypothesized that desmoplastic materials create an impenetrable environment and drive T lymphocytes away from cancer cells, which are necessary for the body’s immune response.  Read More...


Newly Discovered Mutations Impair Key Cell Pathways in Pancreatic Cancer

Cold Spring Harbor, NY — By closely studying a part of the human genome that has not yet been carefully scrutinized in studies of cancer, researchers at Cold Spring Harbor Laboratory (CSHL) have found important new clues to the development of pancreatic cancer.The researchers looked exclusively at small segments of DNA called promoters in samples of tumors taken from 308 pancreatic cancer patients. Promoters are typically located adjacent to genes that they have a role in regulating. An activated promoter can, for example, switch “on” the gene it sits next to. One of many causes of cancer are genes that stay “on” for too long, bypassing natural signals to shut down. This is one way cancers grow out of control. Read More...
2015 website development and design sponsored by Celgene

415 Crossways Park Drive, Suite D, Woodbury, NY 11797
Toll Free: 1-866-789-1000 P: 516-737-1550 F: 516-584-6265